Exane Derivatives Checkpoint Therapeutics, Inc. Call Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CKPT
# of Institutions
3Shares Held
1.91MCall Options Held
0Put Options Held
0About Checkpoint Therapeutics, Inc.
- Ticker CKPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,497,000
- Market Cap $290M
- Description
- Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...